BGM Group (BGM) vs NRX Pharmaceuticals (NRXP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NRX Pharmaceuticals (NRXP) has outperformed BGM Group (BGM) over the past year, losing 19.3% versus a loss of 96.6%. Over five years, NRXP leads with a -97.2% price change compared with -98.3% for BGM. BGM Group is the larger company by market cap ($129.4 million vs $124.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGM | NRXP |
|---|---|---|
| Share price | $9.69 | $2.88 |
| Market cap | $129.40M | $124.48M |
| 1-day change | 0.00% | -0.52% |
| YTD return | -91.00% | +6.64% |
| 1-year return | -96.64% | -19.27% |
| 5-year return | -98.32% | -97.18% |
| EPS (TTM) | $-4.80 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $303.00 | $5.06 |
| 52-week low | $6.45 | $1.62 |
| Distance from 52-week high | -96.80% | -43.13% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +1239.13% |
| Average volume | 6.09K | 865.49K |
| Shares outstanding | 12.69M | 43.30M |
| Employees | — | 29 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NRXP has outperformed BGM by 77.4 percentage points over the past year.
About BGM Group
BGM stock →BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments.
Health Care · Biotechnology: Pharmaceutical Preparations
About NRX Pharmaceuticals
NRXP stock →NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees
BGM vs NRXP FAQ
Which is bigger, BGM Group or NRX Pharmaceuticals?
BGM Group (BGM) is larger, with a market capitalization of $129.40M compared with $124.48M for NRX Pharmaceuticals (NRXP).
Which stock has performed better over the past year, BGM or NRXP?
NRXP returned -19.27% over the past 12 months, compared with -96.64% for BGM (price return, excluding dividends). Past performance does not predict future results.
Are BGM Group and NRX Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.